Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Interventional × Niacin × Clear all

Phase

Status

Completed 5 Unknown 2 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 28 Magnetic Resonance Spectroscopy 20 Biopsy 16 Cyclophosphamide 14 Paclitaxel 8 Nivolumab 8 Bevacizumab 8 Gemcitabine 7 Cisplatin 7 pembrolizumab 6 Docetaxel 6 Vincristine 5 Radiotherapy 5 Radiosurgery 5 Prednisone 5 Fluorouracil 5 Drug Therapy 5 Doxorubicin 5 Carboplatin 5 Capecitabine 5 fludarabine 4 atezolizumab 4 S 1 (combination) 4 Rituximab 4 Radiation 4 Oxaliplatin 4 Lenalidomide 4 Irinotecan 4 Ipilimumab 4 Etoposide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04677049 2026-01-02

Study of Niacin in Glioblastoma

AHS Cancer Control Alberta

Phase 1/2 Suspended

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡